Podcast: How Can We Optimise Treatment Sequencing for mCRC Patients, 3rd Line and Beyond?
Podcast: How Can We Optimise Treatment Sequencing for mCRC Patients, 3rd Line and Beyond?
Experts discuss how physicians can use the latest data to support optimal treatment sequencing
Experts discuss how physicians can use the latest data to support optimal treatment sequencing
Prof. Jenny Seligmann, Prof. Shubham Pant
Listen to a deep-dive into optimising treatment sequencing for patients with metastatic colorectal cancer, 3rd line and beyond, from Dr Jenny Seligmann and Dr Shubham Pant.
In the podcast, the experts discuss what clinicians should consider when making treatment decisions. You'll learn about
- the potential treatment options for patients with advanced mCRC
- the latest available data
- which patient considerations are important when making treatment decisions
Treatment sequencing in advanced mCRC patients
Podcast |
21 min
|
Apr 2023
I agree that this educational programme:
Clinical Takeaways
-
Molecular profiling has an important role in determining treatment options and sequence
-
Physicians should consider patient characteristics, such as comorbidities, toxicities from prior treatments, and overall performance status
-
Treatment from earlier lines of therapy is critical to treatment decisions in the 3rdline and beyond
-
There are a lot of new developments in the third-line treatment space for mCRC patients
- Patients should receive as many treatment options as possible, and this should be considered during sequencing decisions
This educational programme is supported by an Independent Medical Education Grant from Bayer
GI CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer.
Other programmes of interest
Other programmes developed by Prof. Jenny Seligmann

Prof. Jenny Seligmann
Medical Oncologist
University of Leeds
United Kingdom (UK)
Other programmes developed by Prof. Shubham Pant

Prof. Shubham Pant
Medical Oncologist
MD Anderson Cancer Center
United States (US)